CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
119 hedge funds and large institutions have $2.25B invested in China Biologic Products Holdings, Inc. in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 44 increasing their positions, 52 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
15% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 52
63% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 27
Holders
119
Holding in Top 10
5
Calls
$51.5M
Puts
$1.51M
Top Buyers
| 1 | +$55.5M | |
| 2 | +$53.9M | |
| 3 | +$35.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.9M |
| 5 |
CGI
Comgest Global Investors
Paris,
France
|
+$17.1M |
Top Sellers
| 1 | -$59.4M | |
| 2 | -$20.8M | |
| 3 | -$18.9M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$18.9M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$14.3M |